Condition: Vulvar Cancer Stage Ib · Vulvar Cancer Stage II · Lymph Node Metastasis · Sponsor: Queensland Centre for Gynaecological Cancer
This study is an open label, prospective, experimental, randomised clinical trial. The primary aim of this study is to determine whether it is feasible to randomise vulvar cancer patients into one of two treatment arms:1) surgical groin node dissection (as delivered though either a sentinel node biopsy or inguinofemoral lymph node dissection (IFL), or 2) serial high-resolution bilateral groin ultrasound surveillance and clinical examination every 2 months for 12 months.
This description comes directly from the study's public registry record.
Sara Baniahmadi · 07 3346 5073 · s.baniahmadi@uq.edu.au
Brianna Armstrong · 07 3346 5063 · bri.armstrong@uq.edu.au
Always discuss trial participation with your own doctor first.
| St Andrew's War Memorial Hospital | Brisbane, Queensland, Australia | Recruiting |
| Royal Brisbane and Women's Hospital | Brisbane, Queensland, Australia | Recruiting |
| The Wesley Hospital | Brisbane, Queensland, Australia | Not Yet Recruiting |
| Buderim Private Hospital | Sunshine Coast, Queensland, Australia | Recruiting |
| Royal Adelaide Hospital | Adelaide, South Australia, Australia | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06264167